Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 100

Corporate venturing deal net: 12-16 August 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Aug 16, 2019

Daily deal net: August 15, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 15, 2019

Daily deal net: August 12, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 12, 2019

Corporates fuel Hydrogenious LOHC’s $19m round

Royal Vopak, Mitsubishi and Covestro helped the Erlangen–Nuremberg hydrogen storage technology spinout collect $19m in funding.

Aug 12, 2019

Corporate venturing deal net: 5-9 August 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Aug 9, 2019

Daily deal net: August 9, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 9, 2019

Oxford Brain Diagnostics secures funding

Oxford Brain Diagnostics hopes to commercialise an early diagnosis tool for Alzheimer’s disease pioneered through eight years of University of Oxford research.

Aug 9, 2019

Daily deal net August 8, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 8, 2019

Glovo considers changing hands

Glovo, which counts several corporates as investors, has entered discussions with Uber and Deliveroo over a possible acquisition, while SoftBank could potentially provide equity funding.

Aug 8, 2019

Cleave Therapeutics clasps $12m

OUP, Celgene and Astellas Venture Management all supplied a portion of the funding to bring the Caltech-founded cancer drug developer's lifetime funding to $92m.

Aug 8, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here